FWM
AZN icon

FSA Wealth Management’s AstraZeneca AZN Stock Holding History

FSA Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$36.5K Hold
238
– – 0.01% 184
2025
Q2 		$33.3K Buy
238
+188
+376% +$26.3K 0.01% 186
2025
Q1 		$7.35K Hold
50
– – ﹤0.01% 315
2024
Q4 		$6.55K Hold
50
– – ﹤0.01% 358
2024
Q3 		$7.79K Buy
+50
New +$8.07K ﹤0.01% 343
2024
Q1 		$6.78K Hold
50
– – ﹤0.01% 396
2023
Q4 		$7K Buy
+50
New +$6.5K ﹤0.01% 364

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FSA Wealth Management's AZN Position: Q3 2025 in Review

FSA Wealth Management held its AstraZeneca (AZN) position steady in Q3 2025 at 238 shares worth $36.5K. The position accounts for 0.01% of the portfolio, ranked #184.

FSA Wealth Management first reported a position in AZN in Q4 2023 and has held it in 7 quarters since. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • FSA Wealth Management held 238 shares of AstraZeneca worth $36.5K as of Q3 2025.
  • FSA Wealth Management left its AstraZeneca share count unchanged in Q3 2025.
  • AstraZeneca made up 0.01% of FSA Wealth Management's portfolio in Q3 2025, its #184 holding.
  • FSA Wealth Management first reported a position in AstraZeneca in Q4 2023 and has held it in 7 quarters since.
  • 1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.